529 related articles for article (PubMed ID: 11777902)
21. Insulin induces heterologous desensitization of G-protein-coupled receptor and insulin-like growth factor I signaling by downregulating beta-arrestin-1.
Dalle S; Imamura T; Rose DW; Worrall DS; Ugi S; Hupfeld CJ; Olefsky JM
Mol Cell Biol; 2002 Sep; 22(17):6272-85. PubMed ID: 12167719
[TBL] [Abstract][Full Text] [Related]
22. Functional antagonism of different G protein-coupled receptor kinases for beta-arrestin-mediated angiotensin II receptor signaling.
Kim J; Ahn S; Ren XR; Whalen EJ; Reiter E; Wei H; Lefkowitz RJ
Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1442-7. PubMed ID: 15671181
[TBL] [Abstract][Full Text] [Related]
23. Arrestin-dependent angiotensin AT1 receptor signaling regulates Akt and mTor-mediated protein synthesis.
Kendall RT; Lee MH; Pleasant DL; Robinson K; Kuppuswamy D; McDermott PJ; Luttrell LM
J Biol Chem; 2014 Sep; 289(38):26155-26166. PubMed ID: 25081544
[TBL] [Abstract][Full Text] [Related]
24. A beta-arrestin-dependent scaffold is associated with prolonged MAPK activation in pseudopodia during protease-activated receptor-2-induced chemotaxis.
Ge L; Ly Y; Hollenberg M; DeFea K
J Biol Chem; 2003 Sep; 278(36):34418-26. PubMed ID: 12821670
[TBL] [Abstract][Full Text] [Related]
25. The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals.
Luttrell LM; Lefkowitz RJ
J Cell Sci; 2002 Feb; 115(Pt 3):455-65. PubMed ID: 11861753
[TBL] [Abstract][Full Text] [Related]
26. beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2.
DeFea KA; Zalevsky J; Thoma MS; Déry O; Mullins RD; Bunnett NW
J Cell Biol; 2000 Mar; 148(6):1267-81. PubMed ID: 10725339
[TBL] [Abstract][Full Text] [Related]
27. Signal transduction at GPCRs: Allosteric activation of the ERK MAPK by β-arrestin.
Kahsai AW; Shah KS; Shim PJ; Lee MA; Shreiber BN; Schwalb AM; Zhang X; Kwon HY; Huang LY; Soderblom EJ; Ahn S; Lefkowitz RJ
Proc Natl Acad Sci U S A; 2023 Oct; 120(43):e2303794120. PubMed ID: 37844230
[TBL] [Abstract][Full Text] [Related]
28. beta-Arrestin 2 expression determines the transcriptional response to lysophosphatidic acid stimulation in murine embryo fibroblasts.
Gesty-Palmer D; El Shewy H; Kohout TA; Luttrell LM
J Biol Chem; 2005 Sep; 280(37):32157-67. PubMed ID: 16027114
[TBL] [Abstract][Full Text] [Related]
29. Receptor/beta-arrestin complex formation and the differential trafficking and resensitization of beta2-adrenergic and angiotensin II type 1A receptors.
Anborgh PH; Seachrist JL; Dale LB; Ferguson SS
Mol Endocrinol; 2000 Dec; 14(12):2040-53. PubMed ID: 11117533
[TBL] [Abstract][Full Text] [Related]
30. Different G protein-coupled receptor kinases govern G protein and beta-arrestin-mediated signaling of V2 vasopressin receptor.
Ren XR; Reiter E; Ahn S; Kim J; Chen W; Lefkowitz RJ
Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1448-53. PubMed ID: 15671180
[TBL] [Abstract][Full Text] [Related]
31. Reciprocal regulation of angiotensin receptor-activated extracellular signal-regulated kinases by beta-arrestins 1 and 2.
Ahn S; Wei H; Garrison TR; Lefkowitz RJ
J Biol Chem; 2004 Feb; 279(9):7807-11. PubMed ID: 14711824
[TBL] [Abstract][Full Text] [Related]
32. Heterologous phosphorylation-induced formation of a stability lock permits regulation of inactive receptors by β-arrestins.
Tóth AD; Prokop S; Gyombolai P; Várnai P; Balla A; Gurevich VV; Hunyady L; Turu G
J Biol Chem; 2018 Jan; 293(3):876-892. PubMed ID: 29146594
[TBL] [Abstract][Full Text] [Related]
33. Arrestin regulates MAPK activation and prevents NADPH oxidase-dependent death of cells expressing CXCR2.
Zhao M; Wimmer A; Trieu K; Discipio RG; Schraufstatter IU
J Biol Chem; 2004 Nov; 279(47):49259-67. PubMed ID: 15364949
[TBL] [Abstract][Full Text] [Related]
34. Gαs is dispensable for β-arrestin coupling but dictates GRK selectivity and is predominant for gene expression regulation by β2-adrenergic receptor.
Burghi V; Paradis JS; Officer A; Adame-Garcia SR; Wu X; Matthees ESF; Barsi-Rhyne B; Ramms DJ; Clubb L; Acosta M; Tamayo P; Bouvier M; Inoue A; von Zastrow M; Hoffmann C; Gutkind JS
J Biol Chem; 2023 Nov; 299(11):105293. PubMed ID: 37774973
[TBL] [Abstract][Full Text] [Related]
35. Beta-arrestin- and dynamin-dependent endocytosis of the AT1 angiotensin receptor.
Gáborik Z; Szaszák M; Szidonya L; Balla B; Paku S; Catt KJ; Clark AJ; Hunyady L
Mol Pharmacol; 2001 Feb; 59(2):239-47. PubMed ID: 11160859
[TBL] [Abstract][Full Text] [Related]
36. Beta-arrestin 2-dependent angiotensin II type 1A receptor-mediated pathway of chemotaxis.
Hunton DL; Barnes WG; Kim J; Ren XR; Violin JD; Reiter E; Milligan G; Patel DD; Lefkowitz RJ
Mol Pharmacol; 2005 Apr; 67(4):1229-36. PubMed ID: 15635042
[TBL] [Abstract][Full Text] [Related]
37. The three α1-adrenoceptor subtypes show different spatio-temporal mechanisms of internalization and ERK1/2 phosphorylation.
Perez-Aso M; Segura V; Montó F; Barettino D; Noguera MA; Milligan G; D'Ocon P
Biochim Biophys Acta; 2013 Oct; 1833(10):2322-33. PubMed ID: 23797059
[TBL] [Abstract][Full Text] [Related]
38. Differential kinetic and spatial patterns of beta-arrestin and G protein-mediated ERK activation by the angiotensin II receptor.
Ahn S; Shenoy SK; Wei H; Lefkowitz RJ
J Biol Chem; 2004 Aug; 279(34):35518-25. PubMed ID: 15205453
[TBL] [Abstract][Full Text] [Related]
39. Phosphorylation of β-arrestin2 at Thr
Cassier E; Gallay N; Bourquard T; Claeysen S; Bockaert J; Crépieux P; Poupon A; Reiter E; Marin P; Vandermoere F
Elife; 2017 Feb; 6():. PubMed ID: 28169830
[TBL] [Abstract][Full Text] [Related]
40. 5-HT
Liu Y; Gibson AW; Levinstein MR; Lesiak AJ; Ong SE; Neumaier JF
ACS Chem Neurosci; 2019 Jul; 10(7):3143-3153. PubMed ID: 30946562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
